Keebeck Alpha, LP Baxter International Inc Transaction History

Keebeck Alpha, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$37.88 - $43.77 $275,880 - $318,776	7,283 New	7,283 $311,000
Q2 2023 Jul 25, 2023	BUY	$39.98 - $47.68 $305,207 - $363,989	7,634 New	7,634 $347,000
Q3 2020 Nov 02, 2020	SELL	$78.33 - $90.73 $257,862 - $298,683	-3,292 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$78.66 - $94.14 $30,677 - $36,714	390 Added 13.44%	3,292 $283,000
Q1 2020 May 06, 2020	SELL	$71.57 - $93.3 $65,057 - $84,809	-909 Reduced 23.85%	2,902 $236,000
Q4 2019 Feb 12, 2020	BUY	$76.7 - $88.45 $292,303 - $337,082	3,811 New	3,811 $319,000

996

449M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.